Newer oral blood thinners were linked to lower nonmajor bleeding risk than warfarin in adults with sickle cell disease, a ...

Agios Pharmaceuticals is seeking accelerated approval from the U.S. FDA for its oral medication mitapivat for treating sickle ...

Following a reimbursement deal with Vertex, people with SCD in Germany will now have greater access to the gene-editing ...

Sickle cell anemia is an inherited blood disorder that can cause debilitating pain crises and put patients at increased risk for infections, among other symptoms. There are several treatments that can ...

A new, interactive application touted as the first of its kind can help people with sickle cell disease (SCD) learn about and communicate with their care team about their pain attacks. People with ...

FTX-6058 is an experimental small molecule treatment for sickle cell disease (SCD) being developed by Fulcrum Therapeutics. It aims to treat patients by raising levels of fetal hemoglobin in cells.

Clinician bias toward people with sickle cell disease (SCD) may be tied to stigma around opioid use, rather than race or chronic pain alone, a new study suggests. “Although patients with sickle cell ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Although approximately 1 in 6 people worldwide are living with a ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Children with sickle cell disease (SCD) may be more likely than ...

A sickle cell disease (SCD) patient in Bahrain received the gene-editing therapy Casgevy (exagamglogene autotemcel), becoming the first patient outside the U.S. to be treated with the drug. Bahrain ...

A European Medicines Agency committee has issued a positive opinion on the gene-editing therapy Casgevy (exagamglogene autotemcel) in treating sickle cell disease (SCD) and transfusion-dependent beta ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Top-line data from the Phase 3 part of RISE UP, a clinical trial ...